New pill may speed recovery from Tick-Borne babesiosis
NCT ID NCT06207370
First seen Nov 21, 2025 · Last updated Jun 15, 2026 · Updated 30 times
Summary
This study tests whether adding an oral drug called tafenoquine to standard antibiotics helps hospitalized adults with babesiosis recover faster. Babesiosis is a tick-borne illness that can cause fever, chills, and fatigue. About 33 participants will receive either tafenoquine or a placebo, and researchers will track how quickly symptoms resolve and whether the infection clears from the blood.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BABESIOSIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Tufts Medical Center
RECRUITINGBoston, Massachusetts, 02111, United States
Contact Email: •••••@•••••
Contact
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.